Differential roles of p300 and PCAF acetyltransferases in muscle differentiation

被引:365
作者
Puri, PL
Sartorelli, V
Yang, XJ
Hamamori, Y
Ogryzko, VV
Howard, BH
Kedes, L
Wang, JYJ
Graessmann, A
Nakatani, Y [1 ]
Levrero, M
机构
[1] NICHHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA
[2] Univ Rome La Sapienza, Gene Express Lab, Fdn Andrea Cesalpino, Policlin Umberto 1,Ist Clin Med 1, I-00161 Rome, Italy
[3] Univ So Calif, Sch Med, Inst Med Genet, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA
[4] Univ Brescia, Sch Med, Inst Chem, I-25100 Brescia, Italy
[5] Free Univ Berlin, Inst Biochem & Mol Biol, Berlin 33, Germany
[6] Univ Cagliari, Ist Med Interna, I-09124 Cagliari, Italy
[7] Univ Calif San Diego, Ctr Mol Genet, Dept Biol, La Jolla, CA 92093 USA
关键词
D O I
10.1016/S1097-2765(00)80005-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PCAF is a histone acetyltransferase that associates with p300/CBP and competes with E1A for access to them. While exogenous expression of PCAF potentiates both MyoD-directed transcription and myogenic differentiation, PCAF inactivation by anti-PCAF antibody microinjection prevents differentiation. MyoD interacts directly with both p300/CBP and PCAF, forming a multimeric protein complex on the promoter elements. Viral transforming factors that interfere with muscle differentiation disrupt this complex without affecting the MyoD-DNA interaction, indicating functional significance of the complex formation. Exogenous expression of PCAF or p300 promotes p21 expression and terminal cell-cycle arrest. Both of these activities are dependent on the histone acetyltransferase activity of PCAF, but not on that of p300. These results indicate that recruitment of histone acetyltransferase activity of PCAF by MyoD, through p300/ CBP, is crucial for activation of the myogenic program.
引用
收藏
页码:35 / 45
页数:11
相关论文
共 49 条
  • [11] GIORDANO A, 1991, ONCOGENE, V6, P481
  • [12] GRAESSMANN M, 1983, METHOD ENZYMOL, V101, P482
  • [13] Synergistic activation of transcription by CBP and p53
    Gu, W
    Shi, XL
    Roeder, RG
    [J]. NATURE, 1997, 387 (6635) : 819 - 823
  • [14] Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
    Gu, W
    Roeder, RG
    [J]. CELL, 1997, 90 (04) : 595 - 606
  • [15] GUO K, 1995, MOL CELL BIOL, V15, P3823
  • [16] CORRELATION OF TERMINAL CELL-CYCLE ARREST OF SKELETAL-MUSCLE WITH INDUCTION OF P21 BY MYOD
    HALEVY, O
    NOVITCH, BG
    SPICER, DB
    SKAPEK, SX
    RHEE, J
    HANNON, GJ
    BEACH, D
    LASSAR, AB
    [J]. SCIENCE, 1995, 267 (5200) : 1018 - 1021
  • [17] Transcription - A growing coactivator network
    Janknecht, R
    Hunter, T
    [J]. NATURE, 1996, 383 (6595) : 22 - 23
  • [18] WIRING DIAGRAMS - REGULATORY CIRCUITS AND THE CONTROL OF SKELETAL MYOGENESIS
    LASSAR, A
    MUNSTERBERG, A
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1994, 6 (03) : 432 - 442
  • [19] RELIEF OF YY1 TRANSCRIPTIONAL REPRESSION BY ADENOVIRUS E1A IS MEDIATED BY E1A-ASSOCIATED PROTEIN P300
    LEE, JS
    GALVIN, KM
    SEE, RH
    ECKNER, R
    LIVINGSTON, D
    MORAN, E
    SHI, Y
    [J]. GENES & DEVELOPMENT, 1995, 9 (10) : 1188 - 1198
  • [20] Binding and modulation of p53 by p300/CBP coactivators
    Lill, NL
    Grossman, SR
    Ginsberg, D
    DeCaprio, J
    Livingston, DM
    [J]. NATURE, 1997, 387 (6635) : 823 - 827